Kinase inhibitors function by targeting specific ATP-binding sites on the kinase enzyme, thereby preventing the transfer of a phosphate group to the substrate protein. This action can disrupt the signaling pathways that are often overactive in cancer cells, leading to their growth and proliferation. The selectivity of kinase inhibitors is crucial, as it determines the efficacy and safety of the drug.
